Cargando…

Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients

Angiomyolipomas (AMLs) are associated with cell fibrosis in kidney of Tuberous Sclerosis Complex patients. The mechanism by which the fibrotic proteins accumulated in AMLs has not been explored. In the present study, we investigated the role of Akt/tuberin/mTOR pathway in the regulation cell fibrosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Sitai, Salas, Tiffanie, Gencaslan, Emre, Li, Baojie, Habib, Samy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196174/
https://www.ncbi.nlm.nih.gov/pubmed/25149531
_version_ 1782339440017932288
author Liang, Sitai
Salas, Tiffanie
Gencaslan, Emre
Li, Baojie
Habib, Samy L.
author_facet Liang, Sitai
Salas, Tiffanie
Gencaslan, Emre
Li, Baojie
Habib, Samy L.
author_sort Liang, Sitai
collection PubMed
description Angiomyolipomas (AMLs) are associated with cell fibrosis in kidney of Tuberous Sclerosis Complex patients. The mechanism by which the fibrotic proteins accumulated in AMLs has not been explored. In the present study, we investigated the role of Akt/tuberin/mTOR pathway in the regulation cell fibrosis proteins. AML cells that expressed low levels of tuberin showed less expression of N-cadherin and higher of vimentin proteins compared to HEK293 cells. AML cells infected with Ad-tuberin showed a significant decrease in vimentin and an increase in N-cadherin protein expression. In addition, cells treated with rapamycin showed a significant increase in p-Akt and a decrease in p-p70S6K that was associated with a decrease expression of vimentin and a slight increase expression in N-cadherin. On the other hand, cells treated with Akt inhibitor revealed a significant decrease in p-Akt and p-p70S6K that was associated with a significant decrease in vimentin and an increase in N-cadherin expression. In addition, cells transfected with DN-Akt or DN-S6K show significant increase expression in N-cadherin and a decrease in vimentin. Moreover, cells transfected with siRNA against rictor or siRNA against raptor resulted in a decrease in vimentin and an increase N-cadherin expression. Kidney tumors from TSC patients showed significant decrease in N-cadherin and significant increased in vimentin protein expression compared to control kidney tissues. These data comprise the first report to provide the role of Akt/tuberin/mTORC1/2 in the regulation of N-cadherin and vimentin that are involved in the progression of fibrosis in kidney tumor of TSC patients.
format Online
Article
Text
id pubmed-4196174
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-41961742014-10-21 Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients Liang, Sitai Salas, Tiffanie Gencaslan, Emre Li, Baojie Habib, Samy L. Oncotarget Research Paper Angiomyolipomas (AMLs) are associated with cell fibrosis in kidney of Tuberous Sclerosis Complex patients. The mechanism by which the fibrotic proteins accumulated in AMLs has not been explored. In the present study, we investigated the role of Akt/tuberin/mTOR pathway in the regulation cell fibrosis proteins. AML cells that expressed low levels of tuberin showed less expression of N-cadherin and higher of vimentin proteins compared to HEK293 cells. AML cells infected with Ad-tuberin showed a significant decrease in vimentin and an increase in N-cadherin protein expression. In addition, cells treated with rapamycin showed a significant increase in p-Akt and a decrease in p-p70S6K that was associated with a decrease expression of vimentin and a slight increase expression in N-cadherin. On the other hand, cells treated with Akt inhibitor revealed a significant decrease in p-Akt and p-p70S6K that was associated with a significant decrease in vimentin and an increase in N-cadherin expression. In addition, cells transfected with DN-Akt or DN-S6K show significant increase expression in N-cadherin and a decrease in vimentin. Moreover, cells transfected with siRNA against rictor or siRNA against raptor resulted in a decrease in vimentin and an increase N-cadherin expression. Kidney tumors from TSC patients showed significant decrease in N-cadherin and significant increased in vimentin protein expression compared to control kidney tissues. These data comprise the first report to provide the role of Akt/tuberin/mTORC1/2 in the regulation of N-cadherin and vimentin that are involved in the progression of fibrosis in kidney tumor of TSC patients. Impact Journals LLC 2014-07-13 /pmc/articles/PMC4196174/ /pubmed/25149531 Text en Copyright: © 2014 Liang et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Liang, Sitai
Salas, Tiffanie
Gencaslan, Emre
Li, Baojie
Habib, Samy L.
Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients
title Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients
title_full Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients
title_fullStr Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients
title_full_unstemmed Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients
title_short Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients
title_sort tuberin-deficiency downregulates n-cadherin and upregulates vimentin in kidney tumor of tsc patients
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196174/
https://www.ncbi.nlm.nih.gov/pubmed/25149531
work_keys_str_mv AT liangsitai tuberindeficiencydownregulatesncadherinandupregulatesvimentininkidneytumoroftscpatients
AT salastiffanie tuberindeficiencydownregulatesncadherinandupregulatesvimentininkidneytumoroftscpatients
AT gencaslanemre tuberindeficiencydownregulatesncadherinandupregulatesvimentininkidneytumoroftscpatients
AT libaojie tuberindeficiencydownregulatesncadherinandupregulatesvimentininkidneytumoroftscpatients
AT habibsamyl tuberindeficiencydownregulatesncadherinandupregulatesvimentininkidneytumoroftscpatients